Table 1 Clinical characteristics of PD patients
From: Retinal functional and structural changes in patients with Parkinson’s disease
PD patients (n = 50) | |||
|---|---|---|---|
Disease duration in years [mean (SD)] | 3.64(2.32) | ||
H & Y staging [mean (SD)] | 2.59(0.81) | ||
UPDRS [mean (SD)] | Motor | Tremor | 5.52(3.01) |
Rigidity | 5.26(2.5) | ||
Postural instability | 0.9(0.5) | ||
Bradykinesia | 1.24(0.55) | ||
Total Motor | 22.04(8.45) | ||
Mentation | 1.5(1.35) | ||
ADL | 7.64(5.18) | ||
Complication | 2.14(2.29) | ||
Total score | 33.44(15.12) | ||
Anti-parkinsonian medications | Levodopa | 42 (84%) | |
Pramipexole | 31 (62%) | ||
Amantadine | 18 (36%) | ||
Biperiden | 24 (48%) | ||
Selegiline | 12 (24%) | ||